The trademark application COQUERDI was filed by Summit Therapeutics Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on November 12, 2020, and it was registered by office on February 19, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for treatment of Clostridioides difficile infection
Pharmaceuticals compositions
Pharmaceuticals formulations
Antibiotics
Pharmaceutical formulations for treatment of Clostridioides difficile infection.